Literature DB >> 21036354

Traumatic brain injury and severe uncontrolled haemorrhage with short delay pre-hospital resuscitation in a swine model.

Kohsuke Teranishi1, Anke Scultetus, Ashraful Haque, Susan Stern, Nora Philbin, Jennifer Rice, Todd Johnson, Charles Auker, Richard McCarron, Daniel Freilich, Françoise Arnaud.   

Abstract

INTRODUCTION: Unavailability of blood (and oxygen delivery) for pre-hospital resuscitation in haemorrhagic shock patients are major problems, supporting the importance for novel resuscitation strategies. In a combined polytrauma model of uncontrolled haemorrhage and traumatic brain injury (TBI) in swine, we investigated if pre-hospital administration of the haemoglobin based oxygen carrier HBOC-201 will improve tissue oxygenation and physiologic parameters compared to Lactated Ringer's (LR) solution.
MATERIALS AND METHODS: Anaesthetised Yorkshire swine underwent fluid-percussion TBI and Grade III liver laceration. During a 30-min pre-hospital phase, the animals were resuscitated with a single infusion of HBOC-201, LR solution, or nothing (NON). Upon hospital arrival, the animals were given blood or normal saline as needed. Surviving animals were euthanised 6h post-injury. Cerebral blood flow was measured by microsphere injection, and pathology was assessed by gross observation and immunohistochemical analysis.
RESULTS: Mean TBI force (2.4±0.1atm) (means±standard error of the mean) and blood loss (22.5±1.7mL/kg) were similar between groups. Survival at the 6h endpoint was similar in all groups (∼50%). Cerebral perfusion pressure (CPP) and brain tissue oxygen tension were significantly greater in HBOC-201 as compared with LR animals (p<0.005). Mean arterial pressure (MAP) and mean pulmonary artery pressure (MPAP) were not significantly different amongst groups. Blood transfusion requirements were delayed in HBOC-201 animals. Animals treated with HBOC-201 or LR showed no immunohistopathological differences in glial fibrillary acidic protein (GFAP) and microtubule-associated protein 2 (MAP-2). Severity of subarachnoid and intraparenchymal haemorrhages were similar for HBOC and LR groups.
CONCLUSION: In this polytrauma swine model of uncontrolled haemorrhage and TBI with a 30-min delay to hospital arrival, pre-hospital resuscitation with one bolus of HBOC-201 indicated short term benefits in systemic and cerebrovascular physiological parameters. True clinical benefits of this strategy need to be confirmed on TBI and haemorrhagic shock patients.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21036354     DOI: 10.1016/j.injury.2010.09.042

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  13 in total

Review 1.  Intravenous Fluid Therapy in Traumatic Brain Injury and Decompressive Craniectomy.

Authors:  Hernando Raphael Alvis-Miranda; Sandra Milena Castellar-Leones; Luis Rafael Moscote-Salazar
Journal:  Bull Emerg Trauma       Date:  2014-01

2.  Severe brief pressure-controlled hemorrhagic shock after traumatic brain injury exacerbates functional deficits and long-term neuropathological damage in mice.

Authors:  Joseph N Hemerka; Xianren Wu; C Edward Dixon; Robert H Garman; Jennifer L Exo; David K Shellington; Brian Blasiole; Vincent A Vagni; Keri Janesko-Feldman; Mu Xu; Stephen R Wisniewski; Hülya Bayır; Larry W Jenkins; Robert S B Clark; Samuel A Tisherman; Patrick M Kochanek
Journal:  J Neurotrauma       Date:  2012-08-10       Impact factor: 5.269

3.  Influence of antioxidant therapy on the clinical status of multiple trauma patients. A retrospective single center study.

Authors:  Ovidiu Horea Bedreag; Alexandru Florin Rogobete; Mirela Sărăndan; Alina Carmen Cradigati; Marius Păpurică; Oana Maria Roşu; Loredana Luca; Corina Vernic; Radu Nartiţă; Dorel Săndesc
Journal:  Rom J Anaesth Intensive Care       Date:  2015-10

4.  Storage of nitroglycerin (NTG) admixed with HBOC-201 for 30 days in polyolefin plastic bags: a pilot study.

Authors:  Savita Nigam; Richard McCarron; Francoise Arnaud
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

5.  Fluid therapy in neurotrauma: basic and clinical concepts.

Authors:  Hernando Raphael Alvis-Miranda; Andres M Rubiano; Juan C Puyana; Gabriel Alcala-Cerra; Luis Rafael Moscote-Salazar
Journal:  Rev Health Care       Date:  2014

6.  Fluid resuscitation of uncontrolled hemorrhage using a hemoglobin-based oxygen carrier: effect of traumatic brain injury.

Authors:  Nathan J White; Xu Wang; Nicole Bradbury; Paula F Moon-Massat; Daniel Freilich; Charles Auker; Richard McCarron; Anke Scultetus; Susan A Stern
Journal:  Shock       Date:  2013-02       Impact factor: 3.454

7.  A systematic review of large animal models of combined traumatic brain injury and hemorrhagic shock.

Authors:  Andrew R Mayer; Andrew B Dodd; Meghan S Vermillion; David D Stephenson; Irshad H Chaudry; Denis E Bragin; Andrew P Gigliotti; Rebecca J Dodd; Benjamin C Wasserott; Priyank Shukla; Rachel Kinsler; Sheila M Alonzo
Journal:  Neurosci Biobehav Rev       Date:  2019-06-27       Impact factor: 8.989

8.  Review of the UBC Porcine Model of Traumatic Spinal Cord Injury.

Authors:  Kyoung-Tae Kim; Femke Streijger; Neda Manouchehri; Kitty So; Katelyn Shortt; Elena B Okon; Seth Tigchelaar; Peter Cripton; Brian K Kwon
Journal:  J Korean Neurosurg Soc       Date:  2018-08-31

9.  A porcine polytrauma model with two different degrees of hemorrhagic shock: outcome related to trauma within the first 48 h.

Authors:  D Eschbach; T Steinfeldt; F Hildebrand; M Frink; K Schöller; M Sassen; T Wiesmann; F Debus; N Vogt; E Uhl; H Wulf; S Ruchholtz; H C Pape; K Horst
Journal:  Eur J Med Res       Date:  2015-09-04       Impact factor: 2.175

Review 10.  New perspectives of volemic resuscitation in polytrauma patients: a review.

Authors:  Ovidiu Horea Bedreag; Marius Papurica; Alexandru Florin Rogobete; Mirela Sarandan; Carmen Alina Cradigati; Corina Vernic; Corina Maria Dumbuleu; Radu Nartita; Dorel Sandesc
Journal:  Burns Trauma       Date:  2016-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.